Ask AI
ProCE Banner Activity

Dopamine Detours: New Paths for Positive, Negative & Cognitive Symptoms

Slideset

Emerging research is reshaping schizophrenia care, offering pathways to address persistent symptoms while mitigating adverse events tied to traditional therapies. This slideset highlights new strategies to individualize treatment, improve adherence, and reduce psychosocial burdens for patients navigating the challenges of schizophrenia.

Released: December 09, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb. 

Bristol Myers Squibb

Target Audience

This activity is intended for healthcare professionals caring for patients with schizophrenia including psychiatrists, physicians, nurse practitioners, physician associates, registered nurses, pharmacists, social workers, and psychologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the mechanisms of action and pharmacokinetic profiles of novel and emerging therapeutic agents for schizophrenia, extending beyond traditional antidopaminergic antipsychotics

  • Compare the efficacy and safety data of novel and emerging agents in the treatment of schizophrenia

  • Describe the potential of novel antipsychotic therapies to address unmet needs and transform clinical practice in schizophrenia management